Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLSAI.L Regulatory News (LSAI)

  • There is currently no data for LSAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update and Directorate Changes

11 Feb 2021 07:00

RNS Number : 6873O
Location Sciences Group PLC
11 February 2021
 

11 February 2021

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310 ("MAR"). With the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

Location Sciences Group PLC("Location Sciences" or the "Company")

 

Trading Update and Directorate Changes

 

 

Location Sciences (AIM: LSAI), the leading location data insight and verification company, provides the following trading update for the year ended 31 December 2020.

 

Trading Performance

 

Unaudited revenues for the year ended 31 December 2020 are expected to be approximately £1.07 million, a decrease of approximately 12% on 2019 (2019: £1.21 million). The reduction in revenue is due to the ongoing impact of the COVID-19 pandemic on the location-based advertising industry.

 

Unaudited Verify revenues for the year to 31 December 2020 were £0.32 million, compared to £0.50 million in 2019, a reduction of 36%.

 

Unaudited Data & Insights revenues showed a modest improvement, delivering £0.75 million for the year to 31 December 2020, a 6% increase on 2019 (2019: £0.71 million).

 

To mitigate the impact of COVID-19, the Company's directors implemented a cost reduction programme in early 2020 which has led to unaudited administrative expenses being reduced to approximately £1.50 million for the year, a reduction of 41% on 2019 (2019: £2.55 million).

 

The unaudited EBITDA loss is expected to be approximately £0.77 million in the full year period, a decrease of approximately 55% compared to 2019 (2019: EBITDA loss £1.71 million).

 

Impact of COVID-19

 

Verify revenues have continued to be adversely impacted by the significantly reduced advertising spend caused by the pandemic. The anticipated uplift in Verify revenues during Q4 2020 did not materialise and there has been no improvement in the first part of 2021 due to the ongoing restrictions being imposed by governments globally.

 

As reported during 2020, it has been a challenging time for location-based advertising within sectors that rely on people's movement, such as retail and QSR.

 

The outlook for location-based advertising is poor due to the overall impact of the pandemic on the location-based advertising industry, with mainstream media agencies now focused on media delivery rather than adopting new technologies, especially those which risk limiting delivery scale such as Verify.

 

Data & Insights

 

As reported in our interim results, the Company has sought to mitigate the loss of Verify revenues by enlarging and broadening its Data & Insights customer base, including helping to inform the ongoing response to COVID-19. Through its long-term partnership with CACI, Location Sciences is supplying data to support NHS England and members of the Scientific Pandemic Influenza Group on Modelling (SPI-M) in their analysis of how movement of individuals is impacting the reproduction number (R) and growth rate of COVID-19 in the UK.

 

These contract wins enabled the Data & Insights business to grow modestly during 2020, despite the negative impact of the pandemic on some of the business's existing customers.

 

During 2020, the Company developed a new product for the financial services industry which it expects to launch on the Bloomberg Enterprise Access point in the next few months. The product will provide financial analysts with access to market leading footfall data and insights for UK supermarkets to assist them to better measure store performance. A further announcement will be made upon launch of this new product.

 

Verify Status

 

The Company launched an updated version of its Verify Proximity platform at the end of April 2020, providing customers with a clearer picture of how to obtain better value from their location spend and how to drive better performance. Following this in June 2020, Location Sciences launched its Verify Audience product "GeoProtect" in the US. GeoProtect allows brands, agencies and suppliers to check the validity of location-based derived audience segments. It also enables a review of historical movements in contrast to proximity which validates the real time locations as digital advertising campaigns are delivered.

 

Since GeoProtect's launch, the Company has made two important customer wins, both of which were announced in 2020. InMarket, which is a leader in 360-degree consumer intelligence business in the US, and The Spoken Thought, Inc. (trading as Mira), which is a high value audience segment supplier to leading brands and media agencies across the US. Both contracts have growth potential but are facing headwinds in the US market due to the ongoing impact of the pandemic.

 

Despite the product enhancements, the broadening of the product offering with GeoProtect, and the key customer wins during 2020, the performance of Verify has been severely hampered by the restrictions imposed by governments globally to tackle the ongoing pandemic.

 

Further to these developments, in December 2020 shareholders were advised of potential defamation action against the Company pursuant to data manipulation identified by Verify and the findings being reported to its customers. While the threatened legal action - which the Company believes is baseless - has not transpired, the reaction from industry participants has been disappointing. The reality being that the location-based advertising industry is reluctant to adopt technologies which bring transparency to this area, especially now, given the negative impact of the pandemic.

 

The Company will continue to try and solve what it sees as an industry problem. However, the directors believe that, as a knock-on impact of the pandemic, it may now be some years before the location-based advertising industry fully embraces transparency.

 

Cash Resources

 

In March 2020, the Company raised approximately £0.975 million (before expenses) through an equity placing comprising the issue and allotment of 111,430,000 new ordinary shares. An additional approximately £0.07 million was raised through the issue and allotment of 74,057,996 new ordinary shares pursuant to the issue of warrants.

 

In addition to the fundraising activities, the Board made swift cost reductions to mitigate the impact of the downturn in revenues. These included salary reductions for the Board and senior members of the team, a hiring freeze, closure of the London office and staff being furloughed. In addition, with the exception of product development, all operational expenses were reduced to the minimal viable levels from April 2020 following the downturn in the location-based advertising industry caused by the restrictions imposed by governments globally. These actions, together with the data and insight customer wins during the year, have to a large extent offset the impact of the lower Verify revenues on the cash resources of the business.

 

As at 31 December 2020, the Company had cash reserves of approximately £1.1 million (2019: £1.3 million), which the directors believe will now be sufficient for the Company's requirements until 2022.

 

Board Changes

 

In recognition of the need for a leaner business going forward, the size of the Board has been reduced and the Company announces that both Donald Williams and Niall Hogan are stepping down from the Board with immediate effect.

 

The Board would like to thank both Donnie and Niall for their valuable contributions and consider them friends of the Company going forward.

 

Business Review

 

The Board believes that, in part as a consequence of COVID-19, the Company and in particular, Verify, will continue to face a number of trading challenges. This is despite the current relative strength of the Company's working capital position. As a result, the Board is now exploring a number of options for the Company and its businesses and further announcements will be made as and when appropriate.

 

Mark Slade, Chief Executive Officer of Location Sciences, commented: "Like many businesses, 2020 has been an extremely challenging year for Location Sciences and, disappointingly, has halted the momentum we had gained in our verification business. Embracing transparency, which has the side effect of limiting the scale of media delivery, has simply fallen down the priority list for many in the industry. On the positive side, we are encouraged by the durability of our data and insight business and look forward to launching our first product into the financial services industry.

 

"As shown by our results, as a management team we have done everything possible to reduce costs and conserve the cash resources of the business.

 

"The announcement of a business review is the right thing for us to do for shareholders given the ongoing uncertainty caused by the global pandemic and the Board will be evaluating all options open to it."

 

For further information please contact:

 

Location Sciences Group PLC

via Milk & Honey PR

Mark Slade, Chief Executive Officer

 

David Rae, Chief Financial Officer

 

 

 

Allenby Capital Limited (Nominated Adviser)

Tel: +44 (0)20 3328 5656

David Hart

 

 

 

Peterhouse Capital (Broker)

Charles Goodfellow

Eran Zucker

Tel: +44 (0) 20 7220 9791

 

Milk & Honey PR

Tel: +44 (0)20 3637 7310

Kirsty Leighton

 

Jessica Ballinger

 

 

About Location Sciences Group PLC:

 

Location Sciences is a leading independent location data insight and verification company based in the UK.

 

Location Sciences has developed the world's first truly independent location verification solutions, Verify and GeoProtect. Working in partnership with brands, media agencies and suppliers, Location Sciences helps to reduce ad-wastage and improve the effectiveness of location-based advertising campaigns.

 

Location Sciences data and insights products assist companies connecting the digital world with the physical world using mobile location technology data. By combining cutting-edge mobile location data with proprietary machine learning analytics Location Sciences provides customers innovative and valuable insights from location information.

 

Rule 26 website: www.locationsciencesgroup.ai

Verify website: www.locationsciences.ai

LinkedIn: https://www.linkedin.com/company/locationsciences

Twitter: @LocationSci

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCVBLFFFLLBBBV
Date   Source Headline
11th May 20219:05 amRNSSecond Price Monitoring Extn
11th May 20219:00 amRNSPrice Monitoring Extension
6th May 20217:00 amRNSResult of Broker Option
5th May 20212:06 pmRNSSecond Price Monitoring Extn
5th May 20212:00 pmRNSPrice Monitoring Extension
4th May 202111:05 amRNSSecond Price Monitoring Extn
4th May 202111:00 amRNSPrice Monitoring Extension
4th May 20219:05 amRNSSecond Price Monitoring Extn
4th May 20219:00 amRNSPrice Monitoring Extension
4th May 20217:00 amRNSProposed Fundraise of up to £3.85m - Notice of GM
23rd Apr 20212:05 pmRNSSecond Price Monitoring Extn
23rd Apr 20212:00 pmRNSPrice Monitoring Extension
18th Mar 20217:00 amRNSFinal Results for the year ended 31 December 2020
15th Mar 20214:41 pmRNSSecond Price Monitoring Extn
15th Mar 20214:35 pmRNSPrice Monitoring Extension
23rd Feb 202111:00 amRNSPrice Monitoring Extension
19th Feb 20213:36 pmRNSTR-1 Notification of major holdings
11th Feb 202111:06 amRNSSecond Price Monitoring Extn
11th Feb 202111:00 amRNSPrice Monitoring Extension
11th Feb 20219:05 amRNSSecond Price Monitoring Extn
11th Feb 20219:00 amRNSPrice Monitoring Extension
11th Feb 20217:00 amRNSTrading Update and Directorate Changes
3rd Feb 20214:41 pmRNSSecond Price Monitoring Extn
3rd Feb 20214:36 pmRNSPrice Monitoring Extension
28th Jan 20214:41 pmRNSSecond Price Monitoring Extn
28th Jan 20214:36 pmRNSPrice Monitoring Extension
21st Jan 20214:41 pmRNSSecond Price Monitoring Extn
21st Jan 20214:36 pmRNSPrice Monitoring Extension
20th Jan 20214:40 pmRNSSecond Price Monitoring Extn
20th Jan 20214:35 pmRNSPrice Monitoring Extension
18th Dec 20207:00 amRNSHolding(s) in Company
17th Dec 20204:41 pmRNSSecond Price Monitoring Extn
17th Dec 20204:35 pmRNSPrice Monitoring Extension
16th Dec 20204:41 pmRNSSecond Price Monitoring Extn
16th Dec 20204:36 pmRNSPrice Monitoring Extension
14th Dec 20207:00 amRNSPotential Defamation Action Against the Company
30th Nov 20207:00 amRNSNew Contract Win and Trading Update
5th Nov 20203:44 pmRNSHolding(s) in Company
30th Oct 20207:00 amRNSIssue of shares to directors in lieu of fees & TVR
1st Oct 20207:00 amRNSAppointment of Nominated Adviser
17th Sep 202012:43 pmRNSHalf-year Report - Replacement
15th Sep 20207:00 amRNSHalf-year Report
1st Sep 20209:05 amRNSSecond Price Monitoring Extn
1st Sep 20209:00 amRNSPrice Monitoring Extension
1st Sep 20207:00 amRNSContract
27th Jul 20207:00 amRNSTrading Update
3rd Jul 202011:05 amRNSSecond Price Monitoring Extn
3rd Jul 202011:00 amRNSPrice Monitoring Extension
1st Jul 202010:02 amRNSIssue of Equity and Total Voting Rights
16th Jun 202010:36 amRNSIssue of Equity and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.